In an interview , GSK (GSK) CEO Emma Walmsley said the company has been anticipating tariffs on the industry and is “confident” the company can navigate through it, Ashleigh Furlong and Ruth David of Bloomberg reports. The U.S. makes up over half of its business and has been a priority for investments, Walmsley added.
Additionally, in the interview, Walmsley said the company is “excited” about the opportunity in China and does not believe there is a direct impact in terms of China-US relations.
إرسال تعليق